Detecting pathologies at their earliest stages can signifi cantly aff ect patient discomfort, prognosis, therapeutic intervention, survival rates, and recurrence. The use of tissue biomarkers in basic and clinical research and even in clinical practice not only became very common but also their presence as primary endpoints in clinical trials are now very well accepted. The use of tissue biomarkers, and mainly laboratory-measured biomarkers, in clinical set up is somewhat newer, and the suitable approaches to this practice are still in the process of development and refi nement. This review highlights contemporary innovations and explores recent discoveries about markers in lesions of oral cavity.
Introduction
Markers usage in premalignant and malignant lesions of oral cavity has a great potential of early detection and diagnosis of oral cancer. Immunohistochemistry (IHC) could be used as a great tool as an eff ective and advanced marker. Immunochemistry method consists of improvements of immunofl uorescence, immunoperoxidase, and avidin-biotin complex technique. This allows application of certain tests to paraffi n sections of fi xed tissues and the production of highly specifi c antibodies, especially monoclonal antibodies. The drawbacks of this marker tool could be the reliability of the given test is well established and validity with control of results as multiple researchers with diverse skills and knowledge are interpreting the results.
IHC
Tissue markers examined by IHC in precancerous and cancerous lesions: [1, 2] Cell surface markers The epithelial surface antigens of squamous epithelium and their reaction patterns and limitations of the methods are given in Table 1 . [3, 4] The intracellular antigenic constituents and products of squamous epithelium and their reaction patterns and limitations of the methods are given in Table 2 . [5, 6] The antigenic constituents of the basement membrane zone and subepithelial tissue and their reaction patterns and limitations of the methods are given in Table 3 . [7, 8] 
Stromal changes
• The local stromal reaction has been the subject of much speculation, particularly with regard to its role in immunological defense reactions against precancerous and cancerous lesions.
• IHC and electron microscopy made possible to study details of changes in cellular infi ltrates within the epithelium and the connective tissue.
• Sexually transmitted diseases have shown a correlation between marked stromal changes and favorable for tumor patients, thus forming one of the main bases of the immunosurveillance concept.
The following changes can be seen.
Procollagen

1.
A marked increase in procollagen could be demonstrated in the stromal portion of malignant epidermal lesions suggesting increased turnover.
Immunocompetent cells
1. An overall increase in the number of immunocompetent cells correlating with the degree of dysplasia and diff erentiation of carcinomas was found. 2. Lymphocytes, predominantly T-cells (OKT8/ Leu-2a-positive, corresponding to suppressor/cytotoxic cells) appears in the epithelial/tumoral components and in the adjacent stroma. These are clinicopathologic features which help in predicting premalignant behavior. 3. Specifi c genes:
• p53 gene • Proto-oncogenes. 4. Chromosomal losses and gains 5. Image-based ploidy analysis 6. Role of growth factors:
• Fibroblast growth factors • Epidermal growth factor receptor (EGFR). 7. Proliferation markers:
• Proliferating cell nuclear antigen • The nonhistone nuclear protein, Ki67 (MIB 1). 8. Flow cytometry (Ploidy status -DNA content in dysplastic lesions).
Future Importance
Immunoprevention has great potential for future cancer screening as driver mutations were detected in circulating cell-free DNA in patients with premalignant lesions (lung); clonal hematopoiesis shown to be a premalignant state; molecular selection in chemoprevention randomized controlled trial (RCT; oral). [9] Molecular biological markers, markers of epithelial diff erentiation, and genomic markers could be of great value in the diagnosis and prognostic evaluation of oral cancer. [2] Expression of peroxiredoxin -2, tyrosine kinase, and annexin A8 levels is elevated in the saliva of patients having oral cancer. So, using this testing in salivary proteins would be best and effi cient method for detecting the preliminary stages of oral cancer. [10] As the oral cavity malignancies are often not detected until a late stage, the survival rate for cancer of oral cavity has still remained essentially unchanged through the past decades. Eff ective control of oral and oropharyngeal depends on prevention and early diagnosis. Continuing educational campaigns are needed on the local, provincial, and national level to educate the public about the early signs/symptoms associated with this disease. Oral screening by a dentist and/or physician supported with markers could transform oral cancer prevention and early detection. [11] 
Conclusion
There are many promising aspects in the advanced methods presented. The grade of dysplasia of presumably premalignant lesions remains the most important indicator of a malignant potential. Any advanced method must be shown to predict the true biological potential more accurately than conventional histology. 
